TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,252 | -62.1% | 389 | +12.8% | 0.00% | -100.0% |
| Q2 2023 | $8,570 | +72.7% | 345 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $4,963 | +38.5% | 330 | +8.9% | 0.00% | – |
| Q4 2022 | $3,584 | +258.4% | 303 | +203.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | -70.6% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 340 | -14.4% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | -81.0% | 397 | -64.5% | 0.00% | -66.7% |
| Q4 2021 | $21,000 | -74.7% | 1,118 | -55.3% | 0.00% | -86.4% |
| Q3 2021 | $83,000 | -28.4% | 2,500 | -16.7% | 0.02% | -15.4% |
| Q2 2021 | $116,000 | -7.2% | 3,000 | +15.4% | 0.03% | -7.1% |
| Q1 2021 | $125,000 | +60.3% | 2,600 | +73.3% | 0.03% | +47.4% |
| Q4 2020 | $78,000 | +188.9% | 1,500 | +50.0% | 0.02% | +171.4% |
| Q3 2020 | $27,000 | +42.1% | 1,000 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $19,000 | +137.5% | 1,000 | 0.0% | 0.01% | +100.0% |
| Q1 2019 | $8,000 | +100.0% | 1,000 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 1,647,000 | $6,423,000 | 0.45% |
| DAFNA Capital Management LLC | 75,000 | $293,000 | 0.30% |
| Baker Brothers Advisors | 2,199,656 | $8,579,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 71,105 | $277,000 | 0.05% |
| SMITH ASSET MANAGEMENT GROUP LP | 196,684 | $767,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 66,000 | $257,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,000 | $4,000 | 0.01% |
| COLUMBUS CIRCLE INVESTORS | 161,919 | $631,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 455,271 | $1,776,000 | 0.00% |
| BlackRock Fund Advisors | 448,445 | $1,749,000 | 0.00% |